Welcome to the CJU website » LOG IN


Age-specific reference ranges for serum prostate-specific antigen
Professor and Urologist-in-Chief, Director, The Michigan Prostate Center,
Mar 1995 (Vol. 2, Issue 11, Pages( 23 - 29)


Text-Size + 

  • As more is learned about the biomolecular properties and physiology of the glycoprotein, prostate-specific antigen, its clinical usefulness with regard to the diagnosis and management of prostate cancer also will improve. Recent advances, including the development of the concepts of prostate-specific antigen density and velocity as well as the discovery that prostate-specific antigen exists in the serum in several molecular forms, will further improve the clinical utility of this tumor marker. The even more recent discovery that the serum prostate-specific antigen is dependent upon age also has the potential to enhance the clinical usefulness of this tumor marker with regard to the early detection of prostate cancer.

Current Issue

August 2021, Vol.28 No.4
canadian journal of urology